| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2323 |
Injection, natalizumab, 1 mg |
2,947 |
2,541 |
$10.22M |
| J2350 |
Injection, ocrelizumab, 1 mg |
212 |
177 |
$3.67M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,592 |
3,873 |
$270K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,023 |
942 |
$38K |
| 96415 |
|
218 |
181 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
121 |
119 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
344 |
256 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
218 |
181 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
12 |
$1.50 |